Warren Street Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
VCM
VPM
Warren Street Wealth Advisors's VRTX Position: Q1 2026 in Review
Warren Street Wealth Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 10% in Q1 2026, buying an estimated $24.2K and bringing the position to 555 shares worth $248K. The position accounts for 0.06% of the portfolio, ranked #104.
Warren Street Wealth Advisors first reported a position in VRTX in Q1 2025 and has held it in 5 quarters since. The position peaked at $271K in Q2 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Warren Street Wealth Advisors held 555 shares of Vertex Pharmaceuticals worth $248K as of Q1 2026.
- Warren Street Wealth Advisors bought 52 Vertex Pharmaceuticals shares in Q1 2026, an estimated $24.2K.
- Vertex Pharmaceuticals made up 0.06% of Warren Street Wealth Advisors's portfolio in Q1 2026, its #104 holding.
- Warren Street Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
- Warren Street Wealth Advisors's Vertex Pharmaceuticals position peaked at $271K in Q2 2025.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Warren Street Wealth Advisors's 13F filing for Q1 2026, filed 16 Apr 2026.